e-learning
resources
Monograph
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Drug-induced infiltrative lung disease
V. Cottin, P. Bonniaud
Source:
Eur Respir Mon; 2009: 46: 287–318
Journal Issue:
Interstitial Lung Diseases
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Cottin, P. Bonniaud. Drug-induced infiltrative lung disease. Eur Respir Mon; 2009: 46: 287–318
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The new challenge of CTD-ILD: from basic science to clinical setting
Time to breathe: How COVID-19 interacts with interstitial lung disease
Debate – Controversies in interstitial lung disease
Related content which might interest you:
Nodular lung disease
Source: International Congress 2016 – GR2 Radiology
Year: 2016
Diffuse parenchymal lung disease
Source: International Congress 2016 – Clinical year in review
Year: 2016
Diffuse parenchymal lung disease
Source: Eur Respir Rev, 26 (144) 170004; 10.1183/16000617.0004-2017
Year: 2017
Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020
Year: 2020
Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020
Year: 2020
Nitrofurantoin-induced interstitial lung disease
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing
Source: Eur Respir J 2004; 24: 502-505
Year: 2004
Prevalence of progressive fibrosing interstitial lung disease
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Diffuse parenchymal lung diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Diffuse parenchymal lung diseases
Source: ERS Skills Course 2016
Year: 2016
Diffuse parenchymal lung diseases
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Diffuse parenchymal lung diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
Psychological impact of diffuse infiltrative lung disease
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Update on diffuse parenchymal lung disease
Source: Eur Respir Rev 2009; 19: 97-108
Year: 2010
The efficacy of cyclosporine A in patients with clinicoradiologically diagnosed idiopathic nonspecific interstitial pneumonia
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Interstitial lung disease associated with polymyositis-dermatomyositis
Source: Eur Respir J 2005; 26: Suppl. 49, 31s
Year: 2005
The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept